Dean Strinic
Zagreb, 10000, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 17, 2026
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2025
SPONTANEOUS CORONARY ARTERY DISSECTION: CASE REPORTS OF THREE TYPES OF DISSECTION.
Journal: Acta clinica Croatica
Published: March 01, 2024
Stable Gastric Pentadecapeptide BPC 157 Therapy for Monocrotaline-Induced Pulmonary Hypertension in Rats Leads to Prevention and Reversal.
Journal: Biomedicines
Published: May 14, 2021
Multiple Coronary Fistulas as a Rare Cause of Stable Angina Pectoris.
Journal: Case reports in cardiology
Published: May 01, 2021
Clinical Paradox: Anterior Wall Myocardial Infarction with Predominant Inferior ST Elevation and No Variation in Coronary Anatomy in a PAI-1 Homozygote.
Journal: Case reports in cardiology
Published: February 27, 2020
Therapy of the rat hemorrhagic cystitis induced by cyclophosphamide. Stable gastric pentadecapeptide BPC 157, L-arginine, L-NAME.
Journal: European journal of pharmacology
Published: May 04, 2019
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.
Journal: Life sciences
Published: January 05, 2017
Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157.
Journal: Inflammopharmacology
Published: October 26, 2016
Last Updated: 09/26/2026